80094-0001 : Haruto Hangover Defencepatch 1.422 mg/100mg Topical Patch


NDC: 80094-0001
Labeler: Youngwoo Co., Ltd
Product Type: Human OTC Drug
Drug Name: Haruto Hangover Defencepatch
Dosage Form: Topical Patch
Rev. Date: 


NDC Package Codes:

  • 80094-0001-1: 3 MG IN 1 PATCH (80094‑0001‑1)

Active Ingredients:

  • Glutathione

Dosage Strength:

  • 1.422 mg/100mg

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 80094-0001 QR Code

< Prev: 80070-600Next: 80097-001 >

Related Discussions:

glutathione tablet incyto
my mom is diabetic and BP patient n Doctors prescribes so much medicine,due to tht many copmlications arrived like swell... 10 replies
glutathione incyto
i am a pharm student, and i want to know that on which basis is a dose of glutathione 50mg decided? 50mg dose is effecti... 2 replies
Exluton Pills and Glutathione
Is it ok to take Glutathione Capsules when I am currently taking Exluton Pills now? ## Hello po, please pa help naman na... 2 replies
Tablet Oligo Care Lycopene L Arginine Glutathione Carnitine Co Q 10 Methylcobalamin Selenium With Micronutrient
kindly let me know if this drug is authentic: Tablet Oligo Care Lycopene L Arginine Glutathione Carnitine Co Q 10 Methyl... 2 replies
glutathione
adm via picc line. patient is very old...
l glutathione dietary supplement
L-Glutathione 600mg dietary supplement capsules prize in pakistan???????...
Pembrolizumab and Glutathione
My husband is in immunotherapy, undergoing 1 infusion of pembrolizumab ('Keytruda') every three weeks. Is it hel...
HYpromellose+Dextrose+Glutathione
i want to know more about the Dextrose glutathion...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.